Hunting Hill Global Capital’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Hunting Hill Global Capital’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$190	Hold	16,382	–	–	﹤0.01%	89
2025 Q4	$177	Hold	16,382	–	–	﹤0.01%	116
2025 Q3	$431	Hold	16,382	–	–	﹤0.01%	122
2025 Q2	$472	Hold	16,382	–	–	﹤0.01%	126
2025 Q1	$177	Hold	16,382	–	–	﹤0.01%	94
2024 Q4	$360	Hold	16,382	–	–	﹤0.01%	94
2024 Q3	$246	Hold	16,382	–	–	﹤0.01%	75
2024 Q2	$491	Hold	16,382	–	–	﹤0.01%	105
2024 Q1	$418	Hold	16,382	–	–	﹤0.01%	115
2023 Q4	$508	Hold	16,382	–	–	﹤0.01%	110
2023 Q3	$370	Hold	16,382	–	–	﹤0.01%	108
2023 Q2	$1.18K	Hold	16,382	–	–	﹤0.01%	99
2023 Q1	$2.41K	Hold	16,382	–	–	﹤0.01%	61
2022 Q4	$1.64K	Hold	16,382	–	–	﹤0.01%	73
2022 Q3	$1K	Hold	16,382	–	–	﹤0.01%	85
2022 Q2	$1K	Buy	+16,382	New	+$1.23K	﹤0.01%	82

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hunting Hill Global Capital's COEPW Position: Q1 2026 in Review

Hunting Hill Global Capital held its Coeptis Therapeutics Warrants (COEPW) position steady in Q1 2026 at 16,382 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #89.

Hunting Hill Global Capital first reported a position in COEPW in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.41K in Q1 2023. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

Hunting Hill Global Capital held 16,382 shares of Coeptis Therapeutics Warrants worth $190 as of Q1 2026.
Hunting Hill Global Capital left its Coeptis Therapeutics Warrants share count unchanged in Q1 2026.
Coeptis Therapeutics Warrants made up ﹤0.01% of Hunting Hill Global Capital's portfolio in Q1 2026, its #89 holding.
Hunting Hill Global Capital first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and has held it in 16 quarters since.
Hunting Hill Global Capital's Coeptis Therapeutics Warrants position peaked at $2.41K in Q1 2023.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Hunting Hill Global Capital's 13F filing for Q1 2026, filed 15 May 2026.